ArticleCancers2025

Sugammadex Versus Neostigmine in Return to Intended Oncological Therapy After Gastrointestinal Cancer Surgery: A Retrospective Study.

Nicolas A Cortes-Mejia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.